THERAPY OF SECONDARY T-CELL IMMUNODEFICIENCIES WITH BIOLOGICAL SUBSTANCES

被引：0
|
作者：
HADDEN, JW
机构：
来源：
MICROBIOLOGICAL, CHEMOTHERAPEUTICAL AND IMMUNOLOGICAL PROBLEMS IN HIGH RISK PATIENTS | 1989年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：45 / 53
页数：9
相关论文
共 50 条
  • [21] T-Cell Cancer after CAR T-Cell Therapy
    Mitchell, Emily
    Vassiliou, George S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (22): : 2120 - 2121
  • [22] Use of Biological Therapy to Enhance Both Virotherapy and Adoptive T-Cell Therapy for Cancer
    Kottke, Timothy
    Diaz, Rosa M.
    Kaluza, Karen
    Pulido, Jose
    Galivo, Feorillo
    Wongthida, Phonphimon
    Thompson, Jill
    Willmon, Candice
    Barber, Glen N.
    Chester, John
    Selby, Peter
    Strome, Scott
    Harrington, Kevin
    Melcher, Alan
    Vile, Richard G.
    MOLECULAR THERAPY, 2008, 16 (12) : 1910 - 1918
  • [23] CAR T-cell therapies: risk of secondary malignancy of T-cell origin
    Reactions Weekly, 2024, 2019 (1) : 1 - 1
  • [24] Antiviral T-cell therapy
    Leen, Ann M.
    Heslop, Helen E.
    Brenner, Malcolm K.
    IMMUNOLOGICAL REVIEWS, 2014, 258 (01) : 12 - 29
  • [25] T-cell therapy at the threshold
    June, Carl
    Rosenberg, Steven A.
    Sadelain, Michel
    Weber, Jeffrey S.
    NATURE BIOTECHNOLOGY, 2012, 30 (07) : 611 - 614
  • [26] CAR T-CELL THERAPY AND THE EMERGING THREAT OF SECONDARY CANCERS: A TARGETED LOOK
    Bhat, R.
    Ramasamy, P.
    Chhaya, V
    Khambholja, K. M.
    VALUE IN HEALTH, 2024, 27 (12)
  • [27] T-cell lymphoma gene fusion augments T-cell therapy
    Green, Kathleen J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (07) : 1420 - 1420
  • [28] T-cell gene therapy
    Hege, KM
    Roberts, MR
    CURRENT OPINION IN BIOTECHNOLOGY, 1996, 7 (06) : 629 - 634
  • [29] T-Cell Therapy to the Rescue
    Pepple, Kathryn L.
    Van Gelder, Russell N.
    OPHTHALMOLOGY RETINA, 2021, 5 (09): : 835 - 837
  • [30] T-cell therapy for cancer
    Barrett, John
    Bollard, Catherine M.
    IMMUNOTHERAPY, 2012, 4 (04) : 347 - 350
12345